Barclays Maintains Equal-Weight on Healthcare Realty Trust, Lowers Price Target to $24
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Steve Valiquette has maintained an Equal-Weight rating on Healthcare Realty Trust (NYSE:HR) and lowered the price target from $25 to $24.
August 11, 2023 | 11:24 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Barclays has maintained an Equal-Weight rating on Healthcare Realty Trust and lowered the price target from $25 to $24.
The lowering of the price target by Barclays from $25 to $24 indicates a potential decrease in the stock's value. This could lead to a negative short-term impact on the stock's price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100